scholarly journals Improved Alzheimer’s Disease Detection by MRI Using Multimodal Machine Learning Algorithms

Diagnostics ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. 2103
Author(s):  
Gopi Battineni ◽  
Mohmmad Amran Hossain ◽  
Nalini Chintalapudi ◽  
Enea Traini ◽  
Venkata Rao Dhulipalla ◽  
...  

Adult-onset dementia disorders represent a challenge for modern medicine. Alzheimer’s disease (AD) represents the most diffused form of adult-onset dementias. For half a century, the diagnosis of AD was based on clinical and exclusion criteria, with an accuracy of 85%, which did not allow for a definitive diagnosis, which could only be confirmed by post-mortem evaluation. Machine learning research applied to Magnetic Resonance Imaging (MRI) techniques can contribute to a faster diagnosis of AD and may contribute to predicting the evolution of the disease. It was also possible to predict individual dementia of older adults with AD screening data and ML classifiers. To predict the AD subject status, the MRI demographic information and pre-existing conditions of the patient can help to enhance the classifier performance. In this work, we proposed a framework based on supervised learning classifiers in the dementia subject categorization as either AD or non-AD based on longitudinal brain MRI features. Six different supervised classifiers are incorporated for the classification of AD subjects and results mentioned that the gradient boosting algorithm outperforms other models with 97.58% of accuracy.

Genes ◽  
2021 ◽  
Vol 12 (11) ◽  
pp. 1661
Author(s):  
Erik D. Huckvale ◽  
Matthew W. Hodgman ◽  
Brianna B. Greenwood ◽  
Devorah O. Stucki ◽  
Katrisa M. Ward ◽  
...  

The Alzheimer’s Disease Neuroimaging Initiative (ADNI) contains extensive patient measurements (e.g., magnetic resonance imaging [MRI], biometrics, RNA expression, etc.) from Alzheimer’s disease (AD) cases and controls that have recently been used by machine learning algorithms to evaluate AD onset and progression. While using a variety of biomarkers is essential to AD research, highly correlated input features can significantly decrease machine learning model generalizability and performance. Additionally, redundant features unnecessarily increase computational time and resources necessary to train predictive models. Therefore, we used 49,288 biomarkers and 793,600 extracted MRI features to assess feature correlation within the ADNI dataset to determine the extent to which this issue might impact large scale analyses using these data. We found that 93.457% of biomarkers, 92.549% of the gene expression values, and 100% of MRI features were strongly correlated with at least one other feature in ADNI based on our Bonferroni corrected α (p-value ≤ 1.40754 × 10−13). We provide a comprehensive mapping of all ADNI biomarkers to highly correlated features within the dataset. Additionally, we show that significant correlation within the ADNI dataset should be resolved before performing bulk data analyses, and we provide recommendations to address these issues. We anticipate that these recommendations and resources will help guide researchers utilizing the ADNI dataset to increase model performance and reduce the cost and complexity of their analyses.


Author(s):  
Adwait Patil

Abstract: Alzheimer’s disease is one of the neurodegenerative disorders. It initially starts with innocuous symptoms but gradually becomes severe. This disease is so dangerous because there is no treatment, the disease is detected but typically at a later stage. So it is important to detect Alzheimer at an early stage to counter the disease and for a probable recovery for the patient. There are various approaches currently used to detect symptoms of Alzheimer’s disease (AD) at an early stage. The fuzzy system approach is not widely used as it heavily depends on expert knowledge but is quite efficient in detecting AD as it provides a mathematical foundation for interpreting the human cognitive processes. Another more accurate and widely accepted approach is the machine learning detection of AD stages which uses machine learning algorithms like Support Vector Machines (SVMs) , Decision Tree , Random Forests to detect the stage depending on the data provided. The final approach is the Deep Learning approach using multi-modal data that combines image , genetic data and patient data using deep models and then uses the concatenated data to detect the AD stage more efficiently; this method is obscure as it requires huge volumes of data. This paper elaborates on all the three approaches and provides a comparative study about them and which method is more efficient for AD detection. Keywords: Alzheimer’s Disease (AD), Fuzzy System , Machine Learning , Deep Learning , Multimodal data


2019 ◽  
Author(s):  
Daniel Stamate ◽  
Min Kim ◽  
Petroula Proitsi ◽  
Sarah Westwood ◽  
Alison Baird ◽  
...  

AbstractINTRODUCTIONMachine learning (ML) may harbor the potential to capture the metabolic complexity in Alzheimer’s Disease (AD). Here we set out to test the performance of metabolites in blood to categorise AD when compared to CSF biomarkers.METHODSThis study analysed samples from 242 cognitively normal (CN) people and 115 with AD-type dementia utilizing plasma metabolites (n=883). Deep Learning (DL), Extreme Gradient Boosting (XGBoost) and Random Forest (RF) were used to differentiate AD from CN. These models were internally validated using Nested Cross Validation (NCV).RESULTSOn the test data, DL produced the AUC of 0.85 (0.80-0.89), XGBoost produced 0.88 (0.86-0.89) and RF produced 0.85 (0.83-0.87). By comparison, CSF measures of amyloid, p-tau and t-tau (together with age and gender) produced with XGBoost the AUC values of 0.78, 0.83 and 0.87, respectively.DISCUSSIONThis study showed that plasma metabolites have the potential to match the AUC of well-established AD CSF biomarkers in a relatively small cohort. Further studies in independent cohorts are needed to validate whether this specific panel of blood metabolites can separate AD from controls, and how specific it is for AD as compared with other neurodegenerative disorders


2021 ◽  
Vol 2021 ◽  
pp. 1-12
Author(s):  
Morshedul Bari Antor ◽  
A. H. M. Shafayet Jamil ◽  
Maliha Mamtaz ◽  
Mohammad Monirujjaman Khan ◽  
Sultan Aljahdali ◽  
...  

Alzheimer’s disease has been one of the major concerns recently. Around 45 million people are suffering from this disease. Alzheimer’s is a degenerative brain disease with an unspecified cause and pathogenesis which primarily affects older people. The main cause of Alzheimer’s disease is Dementia, which progressively damages the brain cells. People lost their thinking ability, reading ability, and many more from this disease. A machine learning system can reduce this problem by predicting the disease. The main aim is to recognize Dementia among various patients. This paper represents the result and analysis regarding detecting Dementia from various machine learning models. The Open Access Series of Imaging Studies (OASIS) dataset has been used for the development of the system. The dataset is small, but it has some significant values. The dataset has been analyzed and applied in several machine learning models. Support vector machine, logistic regression, decision tree, and random forest have been used for prediction. First, the system has been run without fine-tuning and then with fine-tuning. Comparing the results, it is found that the support vector machine provides the best results among the models. It has the best accuracy in detecting Dementia among numerous patients. The system is simple and can easily help people by detecting Dementia among them.


Recent research in computational engineering have evidenced the design and development numerous intelligent models to analyze medical data and derive inferences related to early diagnosis and prediction of disease severity. In this context, prediction and diagnosis of fatal neurodegenerative diseases that comes under the class of dementia from medical image data is considered as the challenging area of research for many researchers. Recently Alzheimer’s disease is considered as major category of dementia that affects major population. Despite of the development of numerous machine learning models for early diagnosis of Alzheimer’s disease, it is observed that there is a lot more scope of research. Addressing the same, this article presents a systematic literature review of machine learning techniques developed for early diagnosis of Alzheimer’s disease. Furthermore this article includes major categories of machine learning algorithms that include artificial neural networks, Support vector machines and Deep learning based ensemble models that helps the budding researchers to explore the scope of research in predicting Alzheimer’s disease. Implementation results depict the comparative analysis of state of art machine learning mechanisms.


2019 ◽  
Vol 32 (7) ◽  
pp. 1927-1936 ◽  
Author(s):  
Zhao Fan ◽  
Fanyu Xu ◽  
Xuedan Qi ◽  
Cai Li ◽  
Lili Yao

Sign in / Sign up

Export Citation Format

Share Document